RxDoctor Payments Data

Christopher Wiegand, MD

Psychiatry · Tuscon, AZNPI 1780767137

Payments from drug & device makers

$3,948in general payments, 2019–2025

Across 215 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$875
  • AbbVie$753
  • Otsuka America Pharmaceutical, Inc.$365
  • Neurocrine Biosciences, Inc.$355
  • Johnson & Johnson$354
  • Takeda Pharmaceuticals U.S.A., Inc.$265
  • plus $982 from 14 others

What the payments were for

  • Food & beverage$3,948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,948 in reported general payments places this provider in the 85th percentile of 573 psychiatry providers in Arizona.

See all psychiatry providers in Arizona

Medicare billing

Part B allowed, 2024
$58,541
Medicare patients
77
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$45,767
BelsomraSuvorexant21$16,434
Doxepin Hcl21$6,954
Tranylcypromine Sulfate12$5,368
Asenapine Maleate21$4,376
DayvigoLemborexant13$4,334
Lurasidone Hcl28$3,913
Clomipramine Hcl16$3,755
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate12$2,748
Paliperidone ErPaliperidone17$2,370
Clozapine24$1,913
Lamotrigine80$1,886
Desvenlafaxine Succinate ErDesvenlafaxine Succinate27$1,800
Clonazepam117$1,531
Quetiapine Fumarate71$1,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$753$45,76726 claims
MerckBelsomra$15$16,43421 claims
Eisai Inc.Dayvigo$59$4,33413 claims
Almatica Pharma LLCSertraline Hcl$16$1,04051 claims
Teva Pharmaceuticals USA, Inc.Loxapine$875$49020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 573 psychiatry providers in Arizona.

Other psychiatry in Tuscon

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →